The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.
about
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinomaTadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinomaTherapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer.Circulating and disseminated tumour cells in head and neck cancer.Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma.In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients.Immune responses of dendritic cells combined with tumor-derived autophagosome vaccine on hepatocellular carcinoma.Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients.Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.CD45RA-Foxp3high regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma.Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils.
P2860
Q33771631-41DDAA04-CE7E-4FAC-88AB-4480E9A2D4DAQ34105741-FB45C167-590D-442B-89E9-5B327BC7D832Q35067627-107C8763-1B64-44D8-803A-86A4A5329B47Q35189742-350FBC18-0141-415A-9383-A6CD41E33000Q38547000-A3185B42-D8D7-450A-A842-C069A8188865Q38731474-AB918366-0339-4659-8CCF-322AE34ED9C6Q40413430-7BB9D14D-5267-4DE7-B86D-1E7DB457C6CAQ40837686-397BAB5F-7149-4D47-951C-BCEB0FC6A8F3Q40903579-FB4C0B0D-91A4-4B96-9B63-017CD7D9AD73Q41175045-7AF2F454-98CB-4435-9FAE-9259269212F0Q41278675-91A70293-83B1-4C2D-ADA5-67404DEA6C61Q50975027-E429AE85-813C-4823-8C70-23AA3FFF0A8CQ55081546-3047B1B2-A428-4E1A-9BF4-641226F3A7F4
P2860
The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The immune system and head and ...... new therapeutic opportunities.
@en
type
label
The immune system and head and ...... new therapeutic opportunities.
@en
prefLabel
The immune system and head and ...... new therapeutic opportunities.
@en
P2093
P2860
P1433
P1476
The immune system and head and ...... new therapeutic opportunities.
@en
P2093
Donald T Weed
Monika E Freiser
Paolo Serafini
P2860
P2888
P356
10.1007/S12026-013-8462-3
P577
2013-12-01T00:00:00Z
P6179
1032718076